Status:
COMPLETED
Nutritional Supplements & Complementary/Alternative Medicine by Prostate & Breast Cancer Patients
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Collaborating Sponsors:
National Center for Complementary and Integrative Health (NCCIH)
Conditions:
Prostate Cancer
Breast Cancer
Eligibility:
All Genders
21-70 years
Brief Summary
This study was a survey to determine the frequency of Complementary and Alternative Medicine (CAM) use in patients recently diagnosed with breast or prostate cancer who were starting radiation therapy...
Eligibility Criteria
Inclusion
- Inclusion/Exclusions
- Men that have histologically proven carcinoma of the prostate and have chosen some form of radiation therapy as their primary therapy for prostate cancer.
- Women who are undergoing external beam radiation therapy to the breast as primary or adjuvant therapy are eligible.
- All participants must be able to read and write.
- Subjects with dementia and mental retardation that complicates completing the questionnaires will not be enrolled.
- Subjects with known metastatic disease will be excluded.
- There are no age restrictions for this study.
Exclusion
Key Trial Info
Start Date :
December 11 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
109 Patients enrolled
Trial Details
Trial ID
NCT01823549
Start Date
December 11 2002
End Date
December 31 2024
Last Update
December 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States, 43210